MASLD	Metabolic dysfunction-associated steatotic liver disease
NAFLD	Non-alcoholic fatty liver disease
CKD	Chronic kidney disease
MetALD	MASLD and increased alcohol intake
MAFLD	Metabolic dysfunction-associated fatty liver disease
MASH	Metabolic dysfunction-associated steatohepatitis
NASH	Non-alcoholic steatohepatitis
GFR	Glomerular filtration rate
e-GFR	Estimated glomerular filtration rate
m-GFR	Measured glomerular filtration rate
T2DM	Type 2 diabetes mellitus
ALD	Alcoholic liver disease
SLD	Steatotic liver disease
PPAR-γ	Peroxisome proliferator-activated receptor-gamma
TM6SF2	Transmembrane 6 superfamily member 2
MBOAT7	Membrane-bound O-acyltransferase domain-containing 7
GCKR	Glucokinase regulator
PNPLA3	Patatin-like phospholipase domain-containing 3 gene
TMAO	Trimethylamine-N-oxide
TLR	Toll-like receptor
IL-6	Interleukin-6
IL-1β	Interleukin-1 beta
TNF-α	Tumour necrosis factor-alpha
TGF-β	Transforming growth factor-beta
IGF-1	Insulin-like growth factor-1
FGF	Fibroblast growth factor
HR	Hazard ratio
FLI	Fatty liver index
CI	Confidence interval
ICD-10	International Classification of Diseases—tenth revision
UACR	Urinary albumin-creatinine ratio
OR	Odds ratio
RR	Relative risk
LDL	Low-density lipoprotein
HDL	High-density lipoprotein
ANGPTL8	Angiopoietin-like protein 8
RAAS	Renin–angiotensin–aldosterone system
CRP	C-reactive protein
ROS	Reactive oxygen species
NF-KB	Kappa-light-chain-enhancer of activated B cells
ER	Endoplasmic reticulum
PAI-1	Plasminogen activator inhibitor-1